Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR39 | O43194 | 1/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.34 |
| ▸ | MAPT | P10636 | 2/20 | 0.34 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.34 |
| ▸ | MEN1 | O00255 | 2/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | NUDT1 | P36639 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
| ▸ | ATM | Q13315 | 1/20 | 0.30 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24310498 | 0.81 | TSHR (0.44) | CYP1A2MAPTCYP2C9CYP2C19MEN1 | |
| SCHEMBL29566504 | 0.81 | TSHR (0.44) | CYP1A2MAPTCYP2C9CYP2C19MEN1 | |
| SCHEMBL24310010 | 0.76 | GPR39 (0.34) | GPR39CYP1A2MAPTCYP2C9CYP2C19 | |
| SCHEMBL24310446 | 0.76 | MAPT (0.46) | GPR39CYP1A2MAPTCYP2C9CYP2C19 | |
| SCHEMBL26807481 | 0.75 | HTR1A (0.39) | CYP1A2MAPTCYP2C9CYP2C19MEN1 | |
| SCHEMBL24310501 | 0.73 | GPR39 (0.39) | GPR39CYP1A2MAPTCYP2C9CYP2C19 | |
| SCHEMBL24309912 | 0.72 | GPR39 (0.40) | GPR39CYP1A2MAPTCYP2C9CYP2C19 | |
| SCHEMBL24309788 | 0.72 | GCK (0.36) | GPR39CYP1A2MAPTCYP2C9CYP2C19 | |
| SCHEMBL24309752 | 0.71 | MAPK1 (0.57) | GPR39CYP1A2MAPTCYP2C9CYP2C19 | |
| SCHEMBL26807608 | 0.70 | HTR6 (0.45) | MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022076627-A1 | MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2022-04-14 | — | — | WO | disclosed |